Explore the words cloud of the PreventALL project. It provides you a very rough idea of what is the project "PreventALL" about.
The following table provides information about the project.
TECHNISCHE UNIVERSITAET DRESDEN
|Coordinator Country||Germany [DE]|
|Total cost||1˙498˙925 €|
|EC max contribution||1˙498˙925 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2020-05-01 to 2025-04-30|
Take a look of project's partnership.
|1||TECHNISCHE UNIVERSITAET DRESDEN||DE (DRESDEN)||coordinator||1˙498˙925.00|
PreventALL analyzes genetic risk in infection induced ALL and will pioneer leukemia prevention. Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer and it remains a major cause of death in children aged 2-6 years in high-income countries. Exposure to infection, as a potential trigger for the development of childhood ALL was theorized a century ago with several possibilities of exposure to infection in infancy. Consequently, the overall objectives of PreventALL is to systematically analyze postnatally the genetic risk to develop B-cell-precursor (BCP)-ALL and to decipher the infectious mechanism by which exposure to infection causes BCP-ALL. This opens a new horizon for the understanding of leukemia etiology and foster innovation in the development of novel preventive strategies such as diet supplementation or vaccination. To this end, appropriate methods of postnatal risk calculation and in vivo models are needed. We have recently developed the first in vivo murine models with infection-dependent BCP-ALL, based on a genetic predisposition. PreventALL aims to extend this knowledge and to set off for cutting edge research to explore the synergy of genetic predisposition and exposure to infection in BCP-ALL as a proof-of-concept for the role of infection in precancerous disease. In PreventALL Aim 1 will compile novel strategies to identify patients at risk for BCP-ALL, in Aim 2 I will develop preclinical infection-dependent BCP-ALL in vivo models and identify the mechanism how infection triggers BCP-ALL with respect to the genetic predisposition and finally Aim 3 will set up to develop preclinical prevention programs. In summary, PreventALL will establish a significant milestone in the understanding of childhood leukemia and set the starting point for the development of novel and innovative leukemia precision prevention.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREVENTALL" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PREVENTALL" are provided by the European Opendata Portal: CORDIS opendata.
Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin DomainsRead More
Discovery and Characterization of Hydrogen-Based High-Temperature SuperconductorsRead More
The Enemy of the Good: Towards a Theory of Moral ProgressRead More